Loading
Latest filing published 13 Sept 2022 for Cure Pharmaceutical Holding Corp..
No signal scores available.
This profile gathers the share dealings of Robert Steven Davidson in Cure Pharmaceutical Holding Corp. In total, 2 filings cover trades dated from 22 July 2022 to 25 July 2022.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 13 September 2022 with a share grant in Cure Pharmaceutical Holding Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations